CDT To Develop Solid Forms Of Existing Drug Assets; Stock Up

CDT Equity Inc. reported that crystalline forms of existing drug compounds exhibit enhanced physical properties and improved stability, supporting the potential for new formulations. The update is constructive but does not provide clinical efficacy or financial figures, suggesting limited near-term impact beyond product-development momentum.